Tenaya Therapeutics(TNYA)
$0.32-0.01 (-3.30%)
TNYA
Tenaya Therapeutics stock drug pipeline
$0.32
At close:-0.01 (-3.30%)
Want to see TNYA full AI Analyst Report?
Tenaya Therapeutics (TNYA) Drug Pipeline
3,505 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Tn-401 | Arrhythmogenic Right Ventricular Cardiomyopathy | Phase I | Recruiting | Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC | Jan 18, 2024 | ― |
| Tn-201 | Hypertrophic Cardiomyopathy | phase1AndPhase2 | Recruiting | Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM | Apr 18, 2023 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Tn-401 | Phase I | Arrhythmogenic Right Ventricular Cardiomyopathy | Recruiting | Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC | Jan 18, 2024 | ― |
| Tn-201 | phase1AndPhase2 | Hypertrophic Cardiomyopathy | Recruiting | Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM | Apr 18, 2023 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Tenaya Therapeutics, Inc. (TNYA) have in its pipeline
Tenaya Therapeutics TNYA is currently developing the following drugs: Tn-401, Tn-201. These drug candidates are in various stages of clinical development as the company works toward FDA approval.

